Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 18,000 ATNM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 18,000 | n/a |
| Jan 14, 2026 | TENAX THERAPEUTICS, INC. (TENX) | Grant/Award | 30,000 | n/a |
| Nov 19, 2025 | TENAX THERAPEUTICS, INC. (TENX) | Purchase | 93 | $664.95 |
| Jul 3, 2025 | TENAX THERAPEUTICS, INC. (TENX) | Grant/Award | 80,000 | n/a |
| Jun 18, 2025 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 20,100 | n/a |
| Apr 2, 2025 | Actinium Pharmaceuticals, Inc. (ATNM) | Disposition to Issuer | 50,000 | n/a |
| Apr 1, 2025 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 3,167 | n/a |
| Dec 13, 2024 | TENAX THERAPEUTICS, INC. (TENX) | Grant/Award | 100,000 | n/a |
| Nov 14, 2024 | Avalo Therapeutics, Inc. (AVTX) | Purchase | 500 | $6.2K |
| Nov 5, 2024 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 50,000 | n/a |